Tuesday - June 9, 2026
From Salk Institute discovery to patient care: Vitamin D analog shuts down pancreatic cancer's shield in clinical trial
May 26, 2026
LA JOLLA, California, May 26 -- The Salk Institute for Biological Studies issued the following news release:

* * *

From Salk Institute discovery to patient care: Vitamin D analog shuts down pancreatic cancer's shield in clinical trial

Highlights

* Preclinical studies at the Salk Institute laid the foundation for a question now being tested in patients: Can a vitamin D-based therapy "reprogram" a pancreatic tumor's protective . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products